Efficacy of Sodium-Glucose Cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: An updated meta-analysis

BACKGROUND: Recent data suggest that the prevalence of heart failure has increased to approximately 23 million people globally. With increasing advancement in pharmacotherapeutics, Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) have garnered attention among clinicians to treat Heart failure with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamani, Naser, Shaikh, Fahd Niaz, Sarfraz, Saba, Khan, Haider Kamal, Wasim, Muhammad Fahad, Paracha, Anousheh Awais, Almas, Talal, Mookadam, Farouk, Unzek, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Systematic Review / Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458978/
https://www.ncbi.nlm.nih.gov/pubmed/34589210
http://dx.doi.org/10.1016/j.amsu.2021.102796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458978/
https://www.ncbi.nlm.nih.gov/pubmed/34589210
http://dx.doi.org/10.1016/j.amsu.2021.102796

Ejemplares similares